Harmony Biosciences Holdings Inc (HRMY)
33.43
+0.39
(+1.18%)
USD |
NASDAQ |
Nov 05, 16:00
33.00
-0.43
(-1.29%)
After-Hours: 18:06
Harmony Biosciences Holdings Market Cap: 1.907B for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.884B |
| November 01, 2024 | 1.887B |
| October 31, 2024 | 1.832B |
| October 30, 2024 | 1.928B |
| October 29, 2024 | 2.366B |
| October 28, 2024 | 2.039B |
| October 25, 2024 | 1.968B |
| October 24, 2024 | 1.942B |
| October 23, 2024 | 1.942B |
| October 22, 2024 | 1.988B |
| October 21, 2024 | 1.993B |
| October 18, 2024 | 2.019B |
| October 17, 2024 | 1.994B |
| October 16, 2024 | 1.987B |
| October 15, 2024 | 2.025B |
| October 14, 2024 | 2.023B |
| October 11, 2024 | 1.986B |
| October 10, 2024 | 1.985B |
| October 09, 2024 | 1.916B |
| October 08, 2024 | 1.982B |
| October 07, 2024 | 1.961B |
| October 04, 2024 | 1.973B |
| October 03, 2024 | 1.983B |
| October 02, 2024 | 2.029B |
| October 01, 2024 | 2.238B |
| Date | Value |
|---|---|
| September 30, 2024 | 2.281B |
| September 27, 2024 | 2.224B |
| September 26, 2024 | 2.261B |
| September 25, 2024 | 2.119B |
| September 24, 2024 | 2.149B |
| September 23, 2024 | 2.174B |
| September 20, 2024 | 2.233B |
| September 19, 2024 | 2.216B |
| September 18, 2024 | 2.179B |
| September 17, 2024 | 2.206B |
| September 16, 2024 | 2.203B |
| September 13, 2024 | 2.211B |
| September 12, 2024 | 2.146B |
| September 11, 2024 | 2.119B |
| September 10, 2024 | 2.134B |
| September 09, 2024 | 2.097B |
| September 06, 2024 | 2.023B |
| September 05, 2024 | 2.021B |
| September 04, 2024 | 2.048B |
| September 03, 2024 | 2.066B |
| August 30, 2024 | 2.045B |
| August 29, 2024 | 2.032B |
| August 28, 2024 | 2.015B |
| August 27, 2024 | 2.024B |
| August 26, 2024 | 2.055B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.125B
Minimum
Oct 27 2023
3.613B
Maximum
Dec 05 2022
2.211B
Average
2.109B
Median
Jan 31 2022
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 91.13B |
| EyePoint Pharmaceuticals Inc | 621.35M |
| Cassava Sciences Inc | 1.148B |
| Capricor Therapeutics Inc | 600.02M |
| Anavex Life Sciences Corp | 651.65M |
Market Cap Related Metrics
| PE Ratio | 15.84 |
| PS Ratio | 2.844 |
| Price to Book Value | 3.195 |
| Price to Free Cash Flow | 8.808 |
| Price | 33.43 |
| Earnings Yield | 6.31% |
| Operating PE Ratio | 11.06 |
| Normalized PE Ratio | 15.84 |